PALX · Palomino Laboratories Inc.
Market Cap
$453.24M
Shares
27.64M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$3.16M
-19428.3%
FY2025
Diluted EPS
-$0.47
-4181.8%
FY2025
Operating Cash Flow
-$1.28M
-26285%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $3.85M | $2.7M | $6123 | $83.94K | |
| $4.96M | $2.7M | $6123 | — | |
| -$4.96M | -$2.7M | -$6123 | -$83.94K | |
| — | — | $5786 | — | |
| $479 | $890 | $3475 | — | |
| — | — | $0 | — | |
| -$5.18M | -$3.16M | -$16.2K | -$83.94K | |
| USD/shares | -$0.31 | -$0.47 | -$0.01 | -$0.02 |
| USD/shares | -$0.31 | -$0.47 | -$0.01 | -$0.02 |
| shares | — | 6.71M | 1.52M | 5M |
| shares | — | 6.71M | 1.52M | 5M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—